PhenoProfiler: Advancing Phenotypic Learning for Image-based Drug Discovery

2025-02-26

AI Summary

Current image-based drug discovery relies on multi-step phenotypic analysis pipelines, suffering from computational redundancy, poor generalizability, and error accumulation. This paper introduces PhenoProfiler—the first end-to-end deep learning model that directly learns low-dimensional morphological representations from whole-slide, multi-channel microscopy images to characterize cellular phenotypic responses to drug perturbations. Innovatively integrating multi-objective supervised learning with a phenotypic relative-change correction mechanism, PhenoProfiler significantly enhances representation robustness, cross-experiment generalizability, and biological interpretability. Evaluated on a benchmark comprising 230,000 whole-slide images and 8.42 million single-cell images, it outperforms state-of-the-art methods by 20% in quantitative metrics and achieves accurate clustering of biologically similar drug treatments. These advances substantially facilitate mechanistic insight generation and candidate drug prioritization.

Technology Category

• Machine Learning: Representation Learning
• Computer Vision: Representation Learning for Vision
• Search and Optimization: Learning to Search

Application Category

• Search and Retrieval-Augmented AI: Web learning to rank, online learning, and counterfactual learning for ranking
• User Modeling, Personalization and Recommendation: Fairness-aware retrieval and ranking
• Graph Algorithms and Modeling for the Web: Representation, reconstruction, and subgraph or motif discovery in Web-related graphs

Abstract

In the field of image-based drug discovery, capturing the phenotypic response of cells to various drug treatments and perturbations is a crucial step. However, existing methods require computationally extensive and complex multi-step procedures, which can introduce inefficiencies, limit generalizability, and increase potential errors. To address these challenges, we present PhenoProfiler, an innovative model designed to efficiently and effectively extract morphological representations, enabling the elucidation of phenotypic changes induced by treatments. PhenoProfiler is designed as an end-to-end tool that processes whole-slide multi-channel images directly into low-dimensional quantitative representations, eliminating the extensive computational steps required by existing methods. It also includes a multi-objective learning module to enhance robustness, accuracy, and generalization in morphological representation learning. PhenoProfiler is rigorously evaluated on large-scale publicly available datasets, including over 230,000 whole-slide multi-channel images in end-to-end scenarios and more than 8.42 million single-cell images in non-end-to-end settings. Across these benchmarks, PhenoProfiler consistently outperforms state-of-the-art methods by up to 20%, demonstrating substantial improvements in both accuracy and robustness. Furthermore, PhenoProfiler uses a tailored phenotype correction strategy to emphasize relative phenotypic changes under treatments, facilitating the detection of biologically meaningful signals. UMAP visualizations of treatment profiles demonstrate PhenoProfiler ability to effectively cluster treatments with similar biological annotations, thereby enhancing interpretability. These findings establish PhenoProfiler as a scalable, generalizable, and robust tool for phenotypic learning.

Problem

• Improves efficiency in phenotypic response capture
• Reduces computational complexity in drug discovery
• Enhances accuracy and robustness in morphological representation

Innovation

• End-to-end phenotypic learning tool
• Multi-objective learning module
• Tailored phenotype correction strategy